Education
About Us
Working with TipRanks
Follow Us
Astrana Health Inc. (ASTH)
:ASTH
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.20 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)344.58K
Market Cap
$1.44B
Enterprise Value$1.11B
Total Cash (Recent Filing)$342.12M
Total Debt (Recent Filing)$29.39M
Price to Earnings (P/E)58.8
Beta1.08
Next Earnings
Oct 30, 2025EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding49,927,530
10 Day Avg. Volume299,610
30 Day Avg. Volume344,577
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)2.11
Price to Sales (P/S)0.74
P/FCF Ratio34.04
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit3.98
Enterprise Value/Ebitda9.89
Forecast
1Y Price Target
$43.50Price Target Upside43.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe Prospect Health acquisition closed at a lower purchase price than initially expected, allowing a lower pro-forma net leverage ratio.
Financial PerformanceAstrana Health reported second quarter 2025 results with sales ahead of expectations and adjusted EBITDA topping the consensus forecast.
Revenue GrowthRevenue growth seems high, and ASTH's control over data and medical trend is appreciated.
Bears Say
Regulatory ImpactThe Big Beautiful Bill Act could lead to a $200-$250M revenue headwind on a lower-margin book of business.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $21.20 and its highest was $63.20 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.44B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Oct 30, 2025 which is in 22 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Aug 07, 2025. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.349 by -$0.159.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.47.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,927,530 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.19 in its last earnings report, missing expectations of $0.349. Following the earnings report the stock price went up 30.848%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.50 (43.42% Upside)
$43.50 (43.42% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 233.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.87%
12-Months-Change
Fundamentals
Return on Equity
3.50%
Trailing 12-Months
Asset Growth
15.16%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call showcased strong financial performance, highlighted by significant revenue growth and a successful acquisition that improved their leverage position. The company maintained high adjusted EBITDA and increased revenue from full risk contracts, reinforcing its profitability. However, challenges remain, primarily due to Medicaid cost trends and exposure to regulatory changes in Medicaid and health insurance exchanges. Despite these concerns, the overall sentiment is positive given the company's strong execution and strategic advancements.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$43.50
▲(43.42% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.40% Insiders
18.18% Mutual Funds
7.92% Other Institutional Investors
5.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---